
+1 (954) 370-6404
January 19, 2023

A multidisciplinary brain tumor team at Children’s National Hospital successfully performed the first treatment with sonodynamic therapy utilizing low intensity focused ultrasound (LIFU) and 5-aminolevulinic acid (5-ALA) medication on a pediatric patient.
Read more...
January 5, 2023

Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors
We sat down with Dr. Michael Vogelbaum, Program Leader of Neuro-Oncology and Chief of Neurosurgery, to discuss stereotactic radiosurgery for brain tumors.
December 22, 2022

Spotlight: Center for BRCA and Related Genes
Inherited mutations in BRCA1, BRCA2, and other BRCA-related DNA repair genes confer increased risk of multiple tumor types – particularly breast, ovarian, pancreatic, and prostate cancers. Moreover, it is now clear that many cancers can acquire mutations in the BRCA and other related DNA repair genes only in their tumor cells, even though the patient was not born with the genetic mutation.
Latest News
-
Brain tumor team performs first ever LIFU procedure on pediatric DIPG patient
January 19, 2023 -
Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors
January 5, 2023 -
Spotlight: Center for BRCA and Related Genes
December 22, 2022 -
Qatar Rehabilitation Institute Launches Partnership With Leading U.S. Rehabilitation Hospital
December 8, 2022 -
Lenox Hill Hospital – a premier destination in NYC for exceptional care
November 17, 2022 -
What You Need to Know About Minimally Invasive Surgery for Gynecologic Cancers
November 3, 2022 -
Mayo Clinic researchers find new treatment for HPV-associated oral cancer
October 20, 2022 -
CANCER IS TOUGH. AT THE UNIVERSITY OF CHICAGO MEDICINE, HIPEC IS TOUGHER!
October 6, 2022 -
The Cancer and Blood Disease Institute at Children’s Hospital Los Angeles: Leaders in the Field of Pediatric Cancer Care
September 15, 2022 -
GMMI earns URAC Accreditation for its Health Utilization Management Program
September 6, 2022

GMMI is a leading ISO 9001:2015 & ISO/IEC 27001:2013 certified provider of cost containment and medical risk management solutions.
We are Passionate for People. Focused on Client Results. Driven by Legendary Service.
Latest Posts
Brain tumor team performs first ever LIFU procedure on pediatric DIPG patient
January 19, 2023
Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors
January 5, 2023
Spotlight: Center for BRCA and Related Genes
December 22, 2022
Useful Links
Our Contacts
Toll-Free (in the U.S. & Canada): 800-682-6065
Email: info@gmmi.com